Growing evidence suggest that severe COVID-19 patients have higher plasma levels of cytokines, such as IL-1β, IL-6, and IL-10, and concentration of these cytokines in the plasma may differentiate mild, moderate, and severe cases [28,29]. The gene discussed is IL6; the disease is COVID-19.